The company website showcased a news article, published in February, on its website that said: “The company has sold 350 crore tablets (of Dolo-650) since the Covid-19 outbreak in 2020, and earned revenues of ₹ 400 crore in a year.” The CMD of the company, Dilip Surana, has been quoted in the story.
The Income Tax Department on Wednesday conducted searches at the premises of Bengaluru-based pharmaceutical company Micro Labs Ltd, the manufacturer of Dolo-650 tablet for alleged tax evasion. The medicine, prescribed for reducing fever and pain, was widely used during Covid-19 pandemic.
The tax department is looking at financial records and statements of the company as part of the searches, officials said. Further details were not disclosed by the department.
The company is engaged in making and marketing pharmaceutical products and APIs (active pharmaceutical ingredients) and has 17 manufacturing units across the country apart from conducting business overseas.
Its major pharma products are Dolo-650, Amlong, Lubrex, Diapride, Vildapride, Olmat, Avas, Tripride, Bactoclav, Tenepride-M and Arbitel.
The company website showcased a news article, published in February, on its website that said: “The company has sold 350 crore tablets (of Dolo-650) since the Covid-19 outbreak in 2020, and earned revenues of ₹ 400 crore in a year.” The CMD of the company, Dilip Surana, has been quoted in the story.
